Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steeve Provencher

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Thorax|July 6, 2021
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertensionWen-Hui Wu, Sébastien Bonnet, Tsukasa Shimauchi, et al.
Circulation|July 12, 2015
Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial HypertensionFrançois Potus, Grégoire Ruffenach, Abdellaziz Dahou, et al.
International Journal of Molecular Sciences|April 3, 2021
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic ApproachKarima Habbout, Junichi Omura, Charifa Awada, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2020
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial HypertensionGéraldine Vitry, Roxane Paulin, Yann Grobs, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2022
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial HypertensionRuaa Al-Qazazi, Patricia D A Lima, Sasha Z Prisco, et al.
Hypertension (Dallas, Tex. : 1979)|October 24, 2022
Right Ventricular Maladaptation to Pressure Overload in Fischer Rats Is Associated With Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular EnergeticsJason G E Zelt, Virgilio Cadete, Yupu Deng, et al.
The European Respiratory Journal|July 10, 2025
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Canadian Respiratory Journal|December 18, 2010
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelineSanjay Mehta, Doug Helmersen, Steeve Provencher, et al.
Cardiovascular Research|March 28, 2018
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertensionRui Adão, Pedro Mendes-Ferreira, Diana Santos-Ribeiro, et al.
Circulation|January 28, 2026
Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary HypertensionVictoria Toro, Manon Mougin, Coline Brossat, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Thorax|July 6, 2021
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertensionWen-Hui Wu, Sébastien Bonnet, Tsukasa Shimauchi, et al.
Circulation|July 12, 2015
Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial HypertensionFrançois Potus, Grégoire Ruffenach, Abdellaziz Dahou, et al.
International Journal of Molecular Sciences|April 3, 2021
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic ApproachKarima Habbout, Junichi Omura, Charifa Awada, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2020
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial HypertensionGéraldine Vitry, Roxane Paulin, Yann Grobs, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2022
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial HypertensionRuaa Al-Qazazi, Patricia D A Lima, Sasha Z Prisco, et al.
Hypertension (Dallas, Tex. : 1979)|October 24, 2022
Right Ventricular Maladaptation to Pressure Overload in Fischer Rats Is Associated With Profound Deficiency in Adenylate Kinase 1 and Impaired Ventricular EnergeticsJason G E Zelt, Virgilio Cadete, Yupu Deng, et al.
The European Respiratory Journal|July 10, 2025
Pharmacological Inhibition of Epac1 Protects against Pulmonary Fibrosis by Blocking FoxO3a NeddylationKatherine Jankowski, Sarah E Lemay, Daniel Lozano-Ojalvo, et al.
Canadian Respiratory Journal|December 18, 2010
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guidelineSanjay Mehta, Doug Helmersen, Steeve Provencher, et al.
Cardiovascular Research|March 28, 2018
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertensionRui Adão, Pedro Mendes-Ferreira, Diana Santos-Ribeiro, et al.
Circulation|January 28, 2026
Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary HypertensionVictoria Toro, Manon Mougin, Coline Brossat, et al.
Pageof 17